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Abstract 
Most cases of lung cancer have a commonly-understood behavioral etiology. Thus, 
individuals with lung cancer are often blamed for their illness by others and may 
therefore seek to avoid this blame by concealing their diagnosis from others. This study 
sought to determine the prevalence of diagnosis concealment, examine potential 
predictors of concealment, and test parts of a cognitive-affective-behavioral model of the 
effects of concealing a concealable stigma among individuals receiving treatment for 
lung cancer. With regard to predictors of concealment, it was hypothesized that 
concealment would be positively associated with male gender, introversion, and trait 
social anxiety and would be negatively associated with social support and the use of 
seeking guidance and support as a coping strategy. Hypothesized correlates of 
concealment included poorer self-esteem as well as greater anxiety, cancer-specific 
distress, and social avoidance. A sample of 117 participants receiving chemotherapy or 
radiation for stage I-IV non-small cell lung cancer and limited to extensive stage small 
cell lung cancer was recruited during routine outpatient visits. A medical chart review 
was conducted to assess clinical factors and participants completed a standard 
demographic questionnaire as well as measures of coping strategies, introversion, trait 
social anxiety, social avoidance, social support, anxiety, depression, cancer-specific 
distress, self-esteem, perceived stigma, public self-consciousness, and private self-
consciousness. Results indicated that 31% of participants concealed their diagnosis from 
others since their diagnosis and 26% concealed their diagnosis in the month preceding 
vi 
 
their participation in the study. Hypotheses regarding predictors and correlates of 
concealment were not supported. However, exploratory analyses identified use of 
alcohol, recency of a recurrence of lung cancer, use of positive reappraisal as a coping 
strategy, and social support as predictors of concealment as well as internalized shame as 
a correlate of concealment. These findings serve to extend existing literature on 
concealing a concealable stigma and support parts of an existing model on the effects of 
concealment. Future research should aim to test the impacts of concealment in the context 
of certain social situations to examine longitudinal relationships between predictors and 
consequences of concealment.
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Introduction 
 Estimates suggest that in 2010 over 220,000 Americans were diagnosed with lung 
cancer and over 150,000 died of this disease (Jemal, Siegel, Xu, & Ward, 2010). Unlike 
many other forms of cancer, lung cancer is associated with a behavioral etiology (i.e., 
tobacco use). Accordingly, individuals with lung cancer may want to conceal their illness 
due to the potential for stigmatization (Chapple, Ziebland, & McPherson, 2004; Holland, 
Kelly, & Weinberger, 2010; Schonfeld & Timsit, 2008). Surprisingly, the extent to which 
patients conceal a disease such as lung cancer remains largely unstudied. The current 
study sought to evaluate the prevalence and predictors of diagnosis concealment and 
determine whether diagnosis concealment is associated with negative affective, 
behavioral, and self-evaluative implications in a sample of patients diagnosed with lung 
cancer. 
As noted above, lung cancer has a well-established behavioral etiology. Along 
these lines, a recent study asked a sample of British women to rate the degree to which 
they believed patients with various cancers were to blame for their illnesses. Seventy 
percent considered lung cancer patients at least partly to blame for their illness, compared 
to 9% for leukemia patients and 15% for breast cancer patients (Marlow, Waller, & 
Wardle, 2010). Moreover, a study comparing attributions of blame found that lung cancer 
patients blamed themselves for their diagnosis more than their primary caregivers did 
(Lobchuk, Murdoch, McClement, & McPherson, 2008). Thus, individuals with lung 
cancer can be considered at higher risk of stigmatization than individuals with many 
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other forms of cancer due to perceptions of blame. Moreover, some studies have shown 
that illness-related perceived stigma is associated with poorer psychosocial well-being. 
For example, in a recent study of lung cancer patients, perceived stigma was associated 
with poorer social support and dyadic adjustment as well as increased depressive 
symptomatology (Gonzalez & Jacobsen, 2011).  
Although the motivation to conceal one’s lung cancer diagnosis is understandable, 
no published quantitative studies could be found which examined diagnosis concealment 
among individuals with cancer. Most studies of concealment in this population examine 
the ethical issues regarding a physician disclosing a diagnosis to the patient. Only one 
qualitative study could be found which discussed patients’ concealing their cancer 
diagnoses from others. Donovan & Flynn (2007) interviewed men diagnosed with breast 
cancer and found that concealing one’s diagnosis was one of four major themes 
discussed. The rate, predictors, and correlates of concealment among men with this 
stigmatizing diagnosis were not examined (Donovan & Flynn, 2007). To better 
understand this phenomenon, I developed and pilot-tested a brief questionnaire designed 
to assess whether or not individuals with a potentially stigmatizing diagnosis have chosen 
to conceal their illness. Twenty participants in a previous study of lung cancer patients 
were sampled. Seven (35%) reported that they had chosen to conceal their diagnosis from 
family, people at work, or friends around the time their treatment began. In addition, five 
(25%) reported that they were currently concealing their diagnosis from someone.  
 A review of the literature identified no quantitative studies of the predictors of 
diagnosis concealment in people with cancer. In the absence of such research it may be 
instructive to examine qualitative research on this topic in cancer populations and 
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quantitative research in other populations. For example, several qualitative studies have 
suggested that men with cancer are particularly resistant to discussing or disclosing their 
diagnosis (Boehmer & Clark, 2001; Hilton, Emslie, Hunt, Chapple, & Ziebland, 2009; 
Maliski, Rivera, Connor, Lopez, & Litwin, 2008). In a study about deciding whether or 
not to disclose one’s cancer diagnosis, men were more likely than women to conceal their 
diagnosis, citing gender expectations of them as being stoical men (Hilton et al., 2009). 
Another study about men’s experiences with prostate cancer found that men cited the 
need to protect others as a rationale for their reticence to discuss their diagnosis and their 
feelings about its symptoms (Maliski et al., 2008). Other evidence suggests that greater 
introversion and trait social anxiety is associated with greater tendencies to conceal 
personal characteristics likely to be perceived as negative (Cepeda-Benito & Short, 1998; 
Cramer & Lake, 1998; Wismeijer & van Assen, 2008). Along these lines, a study among 
college students indicated that social anxiety was associated with greater general self-
concealment (i.e., the tendency to actively conceal from others) (Endler, Flett, 
Macrodimitris, Corace, & Kocovski, 2002). In contrast, greater social support may have 
the opposite effect. For example, among individuals with HIV, those who reported 
greater social support were less likely to indicate that they had concealed their diagnosis 
(Petrak, Doyle, Smith, Skinner, & Hedge, 2001). Use of certain coping strategies has also 
been associated with concealment. In a qualitative study, Seale & Charteris-Black (2008) 
interviewed individuals with various types of cancer. When deciding whether or not to 
conceal their diagnosis from others, women were more concerned with maintaining their 
social networks than men, suggesting that the coping strategy of seeking social support 
may be associated with concealment (Seale & Charteris-Black, 2008). Similarly, a study 
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of individuals with HIV found that among those who disclosed their diagnosis the desire 
for support was the most often endorsed reason for disclosure (Petrak et al., 2001). 
Together, the results of these studies provide support for investigating associations 
between concealment and gender, introversion, social anxiety, social support, and seeking 
social support in lung cancer patients. Additionally, the literature on impression 
management has also examined the concepts of public and private self-consciousness, the 
tendencies to be concerned about aspects of the self that are easily observable or covert, 
respectively (Leary, 1996). Although these concepts have not been examined as 
predictors of concealment, they merit consideration because of their potential influence 
on individuals’ decisions to conceal. 
No published quantitative studies of the effects of concealing one’s cancer 
diagnosis could be found, and only limited research has been conducted on this topic 
among individuals with other illnesses. However, a model examining the potential effects 
of concealing a concealable and potentially stigmatizing condition is of particular 
importance (Pachankis, 2007; see Figure 1). The following is a brief description of the 
most salient aspects of the model as it might relate to concealing a diagnosis of lung 
cancer.  
 Pachankis (2007) posits that concealment of a potentially stigmatizing condition 
can have negative affective, self-evaluative, and behavioral implications. Individuals who 
choose to conceal such a condition must often make this decision multiple times, even in 
one day, during encounters with family members, friends, and co-workers.  Among those 
who decide to conceal their condition, these repeated reminders of one’s condition may 
lead them to suppress thoughts of their condition (Lane & Wegner, 1995). This thought 
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suppression may place those who conceal their condition at elevated risk of depression, 
anxiety, and distress (Brewin, Watson, McCarthy, Hyman, & Dayson, 1998; Purdon, 
1999). Moreover, these potential affective responses can result in diminished self-esteem 
among these individuals. In addition, individuals who conceal their potentially 
stigmatizing condition may also isolate themselves and avoid others in order to avoid 
these unpleasant consequences of associating with others. 
Although a review of the literature identified no studies that have tested 
hypotheses based on Pachankis’ (2007) model among cancer patients, several studies in 
other populations are instructive. For example, in one study college students who 
reported characteristics that might be considered concealable and stigmatizing (e.g., low 
socioeconomic status, bulimia nervosa, or homosexual sexual orientation) reported 
greater anxiety and depression as well as lower self-esteem than students with potentially 
stigmatizing characteristics that are not concealable (e.g., being overweight or having a 
stutter) (Frable, Platt, & Hoey, 1998). Another study sampled pregnant women just 
before they were to have an abortion and again two years later (Major & Gramzow, 
1999). Results showed an association between secrecy regarding the abortion and 
psychological distress two years after the abortion; additional findings demonstrated that 
this association was mediated by intrusive thoughts as well as suppression of thoughts 
about their abortion (Major & Gramzow, 1999). These findings support extending 
research using Pachankis’ model to the study of the affective, behavioral, and self-
evaluative correlates of concealment among individuals with lung cancer.  
Refining theories of the effects of concealment among individuals with lung 
cancer could help mental providers better attend to their patients’ quality of life and well-
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being. For example, thoracic oncologists may become better equipped to identify 
psychological distress associated with concealment and to address these issues. In 
addition, such research could inform new psychotherapeutic interventions targeting the 
potential affective, behavioral, and self-evaluative effects of concealment. 
The Current Study: Overview, Aims, and Hypotheses 
This study examined the prevalence, predictors, and correlates of concealment of 
one’s lung cancer diagnosis. Participants were individuals receiving chemotherapy and/or 
radiotherapy for treatment for lung cancer, because they may be more likely to have been 
diagnosed more recently than others who are not receiving treatment. Also, because of 
frequent medical appointments, patients receiving treatment may be more likely to be 
making a deliberate decision regarding whether or not to conceal their diagnosis from 
others. Specific aims and hypotheses follow. 
Specific Aim 1. To determine the prevalence of diagnosis concealment among 
lung cancer patients.  
Specific Aim 2. To evaluate potential predictors of concealment. Hypothesis set 
1: It was hypothesized that diagnosis concealment would be positively associated with 
male gender, introversion, and trait social anxiety. It was hypothesized that diagnosis 
concealment would be negatively associated with social support and use of seeking 
guidance and support as a coping strategy. Exploratory analyses: Exploratory analyses 
were conducted to determine whether age, smoking history, marital status, perceived 
stigma, public self-consciousness, and private self-consciousness would be associated 
with concealment. Depending on the outcomes of these exploratory analyses, hierarchical 
regression analyses were planned to determine if psychosocial variables (e.g., social 
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support) predicted concealment over and above relevant demographic and clinical 
variables.  
Specific Aim 3. To evaluate potential affective, behavioral, and self-evaluative 
correlates of concealment of one’s lung cancer diagnosis. Hypothesis set 2: It was 
hypothesized that concealment of one’s lung cancer diagnosis would be positively 
associated with anxiety, depression, cancer-specific distress (affective correlates), social 
avoidance (behavioral correlate), and poorer self-esteem (self-evaluative correlate). 
Exploratory analyses: Mediational analyses were planned to explore whether expected 
associations between concealment and affective outcomes were mediated by behavioral 
and self-evaluative factors. 
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Figure 1. Adapted from Pachankis’ (2007) cognitive-affective-behavioral model for psychological implications of concealing a 
stigma. 
Stigma-Relevant Situation 
 -Salience of stigma 
 -Threat of discovery 
 -Consequences of discovery 
Affective Implications 
 -Anxiety 
 -Depression 
 -Distress 
 
Self-Evaluative Implications 
 -↓ self-esteem 
Behavioral Implication 
 -Social avoidance/isolation 
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Method 
Participants 
 Eligibility criteria for this study were: 1) receiving chemotherapy and/or 
radiotherapy for treatment of non-small cell lung cancer (NSCLC) or small cell lung 
cancer (SCLC), 2) no history of other cancers with the exception of non-melanoma skin 
cancers, 3) ≥ 18 years of age, 4) able to read English, and 5) able to provide informed 
consent. 
Procedure 
Two procedures were used to recruit participants for this study. For both 
procedures, study eligibility was determined in consultation with members of the H. Lee 
Moffitt Cancer Center Thoracic Oncology Program team. The first study procedure 
involved approaching potential participants during routine outpatient visits and 
explaining the study protocol. Those eligible and interested provided written informed 
consent. Participants were given the option of completing the study measures during their 
outpatient visit or taking them home and returning them in a self-addressed stamped 
envelope provided by study staff.  
Those potential participants who were not scheduled to have a routine outpatient 
visit to the H. Lee Moffitt Cancer Center within the next 3 weeks after they were 
identified were recruited via mail. They were mailed a packet containing a cover letter 
that explained the nature of the study and indicated that they would be contacted via 
telephone to discuss participation. The packet also included a card which participants 
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could return in order to decline participation in the study without any further contact, two 
informed consent forms, the study questionnaire, and a pre-addressed postage-paid 
envelope in which they could return the declination card or a signed consent and a 
completed study questionnaire. After the packet was mailed, potential participants were 
contacted by phone and the study protocol was explained. Those eligible and interested 
were asked to sign the consent forms, complete the study questionnaire, and return one 
signed consent form with the completed questionnaire in the provided self-addressed 
stamped envelope. Participants were not compensated for their study participation.  
Measures 
 Demographics and background information. Demographics and background 
information were collected using a standardized self-report form. The variables assessed 
included age, sex, race, ethnicity, education, income, marital status, living arrangements, 
employment status, and menopausal status (for women). In addition, participants 
completed a measure of their smoking history, which was used to classify participants as 
never smokers, former smokers, or current smokers. As part of this assessment, those 
who had smoked at least 100 cigarettes in their lifetime were asked whether or not they 
currently smoke. Both former smokers and current smokers were asked to indicate how 
many cigarettes per day they do or did smoke as well as how many years they smoked. 
Also, current smokers were asked to indicate how many times they have tried to quit 
smoking. Former smokers were asked to indicate how long ago they quit smoking. 
 Clinical information. The following clinical information was assessed via a 
review of patients’ medical records: date of lung cancer diagnosis, disease stage, disease 
type (small cell vs. non-small cell), previous lung cancer treatment, current lung cancer 
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treatment, and ECOG performance status (a measure of overall well-being) (Oken et al., 
1982). 
Diagnosis concealment. Diagnosis concealment was assessed with a brief self-
report measure that was designed and pilot-tested for this study. Respondents were asked 
to indicate whether or not they had chosen to conceal their lung cancer diagnosis (yes/no) 
from anyone within certain specified groups (i.e., family, friends, and coworkers) within 
two time frames: 1) since their cancer diagnosis and 2) within the past month. Those who 
indicated they had chosen to conceal their lung cancer diagnosis were asked to indicate 
their reason(s) for concealing by choosing from a specified list of reasons derived from 
pilot-testing of this questionnaire (e.g., “I didn’t want them to worry about me”). In 
addition, participants were asked to report how much discomfort, on a scale from 0 (no 
discomfort) to 4 (extreme discomfort), disclosing or not disclosing their lung cancer 
diagnosis to others caused in the past month. Lastly, participants were asked to report 
how many occasions in the past month they chose not to disclose their diagnosis. 
Coping. Coping strategies was assessed using the Coping Responses Inventory 
(CRI; (Moos, 1993; Moos, 1993), a 48-item Likert-type instrument which assesses 
specific coping responses via eight subscales. Responses are coded from 0 (not at all) to 
3 (fairly often). Four subscales assess approach coping styles: seeking guidance and 
support, problem solving, logical analysis, and positive reappraisal (Moos, 1993). Four 
subscales assess avoidant coping styles: seeking alternative rewards, emotional discharge, 
cognitive avoidance, and acceptance or resignation (Moos, 1993). The eight individual 
subscales of the CRI have been validated (Moos, 1993) and been shown to have adequate 
internal consistency reliability (α range: .61 - .74) in a sample of ovarian cancer patients 
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(Chan, Ng, Lee, Ngan, & Wong, 2003). In the present study, analyses focused on the 
seeking guidance and support subscale which asks questions such as, “Did you talk with 
a friend about the problem?” In the present study, this scale demonstrated poor internal 
consistency reliability (α = .54). 
Introversion. Introversion was assessed using the Extraversion-Introversion 
subscale of the NEO–Five Factor Inventory (NEO-FFI; (Costa Jr & McCrae, 1992). This 
subscale has 12 items rated on a 5-point Likert-type scale, ranging from 1 (strongly 
disagree) to 5 (strongly agree). Sample items include “I like to have a lot of people 
around me” and “I really enjoy talking to people.” The NEO-FFI has demonstrated 
acceptable reliability and validity in the general population as well as in individuals with 
cancer (Costa Jr & McCrae, 1992; Montgomery et al., 2009). In the present study, this 
scale demonstrated adequate internal consistency reliability (α = .79). 
Trait social anxiety and social avoidance. Trait social anxiety and social 
avoidance were assessed using the Liebowitz Social Anxiety Scale (LSAS; (Liebowitz, 
1987), a 24-item measure which asks respondents to rate the fear/anxiety they experience 
during certain social situations (e.g., speaking up at a meeting) on a 4-point Likert-type 
scale ranging from 0 (none) to 3 (severe). Respondents are then asked to indicate the 
degree to which they would avoid these social interactions. These items are also coded on 
a 4-point Likert-type scale ranging from 0 (never) to 3 (usually) scale. The trait social 
anxiety and social avoidance subscales have demonstrated acceptable reliability and 
validity (Heimberg et al., 1999; Liebowitz, 1987). The social anxiety (α = .92) and social 
avoidance (α = .89) scales demonstrated adequate internal consistency reliabilities in the 
present study. 
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Social support. Social support was assessed using the ENRICHD Social Support 
Instrument (ESSI; (Mitchell et al., 2003; Mitchell et al., 2003), a 5-item Likert-type 
instrument designed to assess emotional support. Responses range from 1 (none of the 
time) to 5 (all of the time). The ESSI has been shown to have acceptable reliability and 
validity (Mitchell et al., 2003; Mitchell et al., 2003). Sample questions include “Is there 
someone available to give you good advice about a problem?” and “Is there someone 
available to you who shows you love and affection?” (Mitchell et al., 2003; Mitchell et 
al., 2003). In the present study, this scale demonstrated adequate internal consistency 
reliability (α = .92). 
Anxiety and depression. Anxiety and depression were assessed using the 
respective Anxiety and Depression scales of the Hospital Anxiety and Depression Scale 
(HADS; (Zigmond & Snaith, 1983). The HADS asks respondents to indicate on a 4-point 
scale (from most of the time to not at all) how often they feel certain ways (e.g., I feel 
tense or “wound up”). The anxiety and depression scales have demonstrated acceptable 
validity and reliability and have been used extensively in studies of patients with cancer 
(Ibbotson, Maguire, Selby, Priestman, & Wallace, 1994; Jacobsen & Jim, 2008). Sample 
reverse coded items include “I can sit at ease and feel relaxed” and “I still enjoy the 
things I used to enjoy.” (Zigmond & Snaith, 1983). The anxiety (α = .66) and depression 
(α = .57) scales demonstrated poor internal consistency reliabilities in the present study. 
Cancer-specific distress. Cancer-specific distress was assessed using the 
intrusion subscale of the Impact of Events Scale – Revised (IES-R; (Weiss & Marmar, 
1997), a 22-item Likert-type scale in which respondents are asked to rate how distressing 
each item is on a scale from 0 (not at all) to 4 (extremely). Sample intrusion subscale 
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items include “Other things kept making me think about it” and “Pictures about it popped 
into my head.” Respondents were instructed to rate items with regard to the diagnosis and 
treatment of their lung cancer. This scale, which has demonstrated acceptable reliability 
and validity, has been extensively used in the cancer population as a measure of cancer-
specific distress (Floyd et al., 2011; Weiss & Marmar, 1997). In the present study, this 
scale demonstrated adequate internal consistency reliability (α = .87). 
Self-esteem. Self-esteem was assessed using the Rosenberg Self-Esteem Scale 
(RSES; (Rosenberg, 1979), a 10-item Likert-type scale in which respondents indicate on 
a 4-point scale the degree to which they agree with statements such as “I feel I do not 
have much to be proud of” and “I certainly feel useless at times.” Responses are scored 
on a scale of 0 (strongly disagree) to 3 (strongly agree). This scale has demonstrated 
adequate reliability and validity and has been used with numerous populations, including 
with individuals with cancer (Greenfield et al., 2010; Rosenberg, 1979). In the present 
study, this scale demonstrated adequate internal consistency reliability (α = .88). 
Perceived stigma. Perceived stigma was assessed using the Social Impact Scale 
(SIS; (Fife & Wright, 2000; Fife & Wright, 2000)), a 24-item Likert-type scale which 
measures the extent to which individuals with an illness believe they are experiencing 
social rejection, financial insecurity, internalized shame, and social isolation as a result of 
their illness. In addition to a total score, the measure yields subscale scores for the four 
aspects of experienced stigma described above. These four subscales have been shown to 
have strong internal consistency reliability (α range: .85 - .90), and though they are 
related, their relatively low zero-order correlations with one another (r range: .28 – .66) 
suggest that they assess divergent aspects of one’s illness-related stigma (Fife & Wright, 
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2000). In the present study, the total perceived stigma scale (α = .92) and the four 
subscales (αs = .69 - .87) demonstrated adequate internal consistency reliabilities.  
 Public and private self-consciousness. Public and private self-consciousness 
were assessed using the respective subscales of the Self-Consciousness Scale – Revised 
(SCS-R; (Scheier & Carver, 1985). Public self-consciousness refers to the tendency to be 
concerned about easily observable aspects of oneself, and private self-consciousness 
refers to the tendency to be concerned about covert aspects of oneself that are not easily 
observable. The 8- and 7-item subscales provide statements and ask respondents to rate 
each on a 4-point Likert-type scale ranging from 0 (not like me at all) to 3 (a lot like me). 
These scales have demonstrated adequate reliability and validity in previous studies 
(Scheier & Carver, 1985). The public self-consciousness (α = .61) and private self-
consciousness (α = .64) subscales demonstrated slightly less than adequate internal 
consistency reliabilities in the present study. 
Statistical Analyses 
Preliminary analyses. The rate of participation was computed, and those who 
declined to participate were compared to those who participated to determine whether 
demographic or clinical differences existed between these two groups. Descriptive 
statistics (e.g., means and standard deviations) were computed to characterize the sample 
in terms of its demographic, clinical, and psychological characteristics. In addition, the 
prevalence of concealment was computed. Along these lines, the number of participants 
who concealed their diagnosis from anyone was computed for both time frames (past 
month and since cancer diagnosis), as well as a summary indicating from whom 
participants chose to conceal their diagnosis and why. 
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Hypothesis testing. Diagnosis concealment was dichotomized to compare 
individuals who did not conceal their diagnosis from anyone in the past month to those 
who did conceal their diagnosis from anyone in the past month. This study also explored 
the possibility that differences existed as a function of from whom participants concealed 
their diagnosis (described below). Separate analyses were conducted for examining 
potential predictors of concealment and correlates of concealment for both time frames 
(i.e., within the past month and since the cancer diagnosis).  
Logistic regression analyses were used to determine the association between 
diagnosis concealment (categorical variable) and hypothesized continuous (e.g., 
introversion) as well as categorical (e.g., gender) predictor variables (Aim 2). Point-
biserial correlational analyses were conducted to determine the associations between 
diagnosis concealment and hypothesized correlates of concealment (e.g., depression) 
(Aim 3). 
Exploratory analyses. Mediational analyses were conducted to explore whether 
the expected relationships of concealment with anxiety, depression, and cancer-specific 
distress are mediated by social avoidance and self-esteem. These analyses followed 
established protocol for determining mediation (Preacher & Hayes, 2008). Preacher & 
Hayes (2008) lay out the following steps (see Figure 2): 
1. The dependent variable (psychological factor) is regressed on the predictor 
(diagnosis concealment). The regression coefficient for the independent 
variable (IV) in this equation is termed c.  
2. The proposed mediator (avoidance/self-esteem) is regressed on the predictor.  
The regression coefficient for the IV in this equation is termed a. 
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3. The dependent variable is regressed on the predictor and mediator. The 
regression coefficient for the mediator is termed b, and the new regression 
coefficient for the predictor in this equation is termed c’. 
To satisfy the requirements for mediation the product of ab, the indirect effect, 
must be significantly different from zero. Bootstrapping is used to derive an estimate of 
and 95% confidence interval for the indirect effect (Preacher & Hayes, 2008), and this 
confidence interval is examined to determine whether or not it includes zero.  
An exploratory hierarchical logistic regression analysis was planned to determine 
whether psychosocial factors accounted for unique variance in diagnosis concealment 
above and beyond that contributed by relevant demographic, clinical, and smoking 
variables. However, given the lack of support for hypothesized associations between 
psychosocial factors and concealment (see below), these logistic regression analyses were 
not conducted. 
Additional exploratory chi-square analyses were conducted to identify potential 
psychological predictors of discomfort associated with concealing or disclosing one’s 
diagnosis in the past month. Lastly, an exploratory correlational analysis was conducted 
to attempt to replicate the association between perceived stigma and depression observed 
by Gonzalez & Jacobsen (2011). 
Power analyses. Pilot-testing of the diagnosis concealment measure indicated 
that about 30% of lung cancer patients concealed their lung cancer diagnosis from anyone 
during treatment. Thus, power analysis for this study presumed that 30% of the sample 
would report concealing their diagnosis and 70% will not. 
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Hypothesis set 1. A power analysis for a logistic regression was run using Power 
and Precision 2.0 (Biostat, 2000). This power analysis indicated that with a Type I error 
rate of .05 (two-tailed) and power equal to .80, a sample of 86 participants was necessary 
in order to detect an OR = 2.06, which is equivalent to a small to medium effect size (d = 
0.4) (Chinn, 2000).  
Hypothesis set 2. A power analysis for a point-biserial correlation was run using 
Power and Precision 2.0 (Biostat, 2000). This power analysis indicated that with a Type I 
error rate of .05 (two-tailed) and power equal to .80, a sample size of 120 participants 
would be necessary in order to detect a small to medium effect size of r = .25.  
Based on these analyses, the current study aimed to conduct analyses with data 
from 120 participants. With the consent of the dissertation committee, analyses were 
conducted with data from 117 participants. 
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Figure 2. Path diagram for the indirect effect of a predictor on a dependent variable 
through a mediator. 
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Results 
Participants 
Participant flow is shown in Figure 3. One thousand four hundred forty-seven 
individuals were screened for this study; of these, 1,067 were ineligible based on medical 
record reviews (e.g., history of other cancer, not receiving chemotherapy). One hundred 
eight-four were potentially eligible for participation but were not approached for 
recruitment due to unavailability of research personnel. The remaining 196 participants 
were approached for participation; of these, an additional 4 were deemed ineligible 
before consent, 39 refused to participate, and 159 agreed to participate (83% of those 
eligible). Of those who agreed to participate, 4 withdrew from the study, 29 never 
completed the study measures and could not be reached, and 3 were found to be ineligible 
after they participated. Thus, analyses were conducted on the 117 participants who had 
evaluable data. The 159 patients who agreed to participate in the study did not differ in 
terms of age, gender, or race from the 39 patients who declined to participate, ps ≥ .24. 
 Participant demographic and clinical characteristics are shown in Tables 1 and 2. 
Participants ranged in age from 36 to 85 years (M = 64.22; SD = 9.66). The majority of 
the participants were high school graduates (70%), married (62%), and White (82%). 
Twenty-six participants (22%) were never smokers, and 91 (78%) were previous smokers 
or current smokers at the time of the study visit. Mean body mass index for this sample 
was 26.33 (SD = 5.19), which indicates that the average participant was slightly 
overweight. On average, participants were 20.56 months (SD = 27.92) from their original 
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lung cancer diagnosis. Twenty-seven participants (23%) had a recurrence of their lung 
cancer, thirty-seven (32%) had a surgical resection of this cancer, and 50 (43%) had been 
treated with radiation therapy.  
Prevalence of concealment and reasons for concealment 
 To address Aim 1, the number of participants who reported concealing their 
diagnosis from anyone was calculated using their responses to items asking whether they 
concealed from individuals in certain groups (e.g., “Did you choose not to tell a close 
family member?”). Concealment was calculated separately for those who concealed from 
anyone since their diagnosis and those who concealed from anyone in the past month (see 
Tables 3 and 4 for frequencies). 
 Thirty-six participants (31%) reported concealing since their diagnosis. The 
majority (n = 25, 69%) reported concealing from a casual friend since their diagnosis. 
Thirty participants (26%) reported concealing in the past month. The majority (n = 20, 
67%) reported concealing from a casual friend since their diagnosis. 
 Reasons for diagnosis concealment are shown in Tables 5 and 6. A commonly-
endorsed reason for diagnosis concealment was concern that one’s family or friends
 would worry about the patient. This was evident among participants who 
concealed since diagnosis and in the past month. 
Comparing demographics between concealers and non-concealers 
To address hypothesis set 1, comparisons were made between those who 
concealed and those who did not on demographic measures (see Tables 7 and 8). 
Contrary to expectations, gender was not associated with concealment since diagnosis (p 
= .46) or in the past month (p = .67). Exploratory analyses also indicated that age, history 
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of smoking, and marital status were not associated with concealment since diagnosis or in 
the past month (ps ≥ .07). Additional exploratory analyses indicated that those who 
concealed in the past month were more likely to report drinking alcohol in the past month 
(p = .04); no differences based on alcohol use were observed for concealment since 
diagnosis (p = .09). 
Comparing clinical factors between concealers and non-concealers 
 Exploratory analyses were conducted to identify potential clinical predictors of 
concealment (see Tables 9 and 10). Analyses indicated that among patients with a 
recurrence, those who recurred more recently were more likely to report concealing in the 
past month (p < 0.01); no differences based on recency of recurrence were observed for 
concealment since diagnosis (p = .06). Body mass index, time since diagnosis, time since 
resection, time since radiation, type of lung cancer (NSCLC vs. SCLC), disease stage, 
ECOG performance status, use of antidepressants, and use of sedative/hypnotics were not 
associated with diagnosis concealment since diagnosis or in the past month (ps ≥ .06). 
Similarly, no associations were found between diagnosis concealment since diagnosis or 
in the past month and whether participants had a recurrence, a surgical resection of their 
lung cancer, radiotherapy, or chemotherapy (ps ≥ .13). 
Examining potential psychological predictors of diagnosis concealment 
To address hypothesis set 1, analyses were conducted to identify potential 
psychological predictors of concealment (see Tables 11 and 12). Contrary to 
expectations, introversion, social anxiety, social support, and use of seeking guidance and 
support as a coping strategy were not associated with concealment since diagnosis (ps ≥ 
.25) or in the past month (ps ≥ .15). In addition to the planned analyses, exploratory 
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analyses were conducted to identify potential psychological predictors of diagnosis 
concealment (see Tables 13 and 14). Those who reported greater use of positive 
reappraisal as a coping strategy were more likely to report concealing their diagnosis in 
the past month (p = .02). Private self-consciousness and public self-consciousness were 
not associated with diagnosis concealment since diagnosis or in the past month (ps ≥ .13). 
In addition, diagnosis concealment since diagnosis or in the past month were not 
associated with use of logical analysis, problem-solving, cognitive avoidance, acceptance 
or resignation, seeking alternative rewards, or emotional discharge as coping strategies 
(ps ≥ .13). 
 Additional exploratory analyses were conducted to identify potential 
psychological predictors of discomfort associated with concealing or disclosing one’s 
diagnosis in the past month (see Table 15). Social anxiety was positively associated with 
the discomfort participants reported around disclosing or concealing their diagnosis (p < 
.01). Discomfort with concealing or disclosing in the past month was not associated with 
introversion, social support, or use of seeking guidance and support as a coping strategy 
(ps ≥ .48). 
Examining potential correlates of concealment 
To address hypothesis set 2, analyses were conducted to examine potential 
psychological correlates of diagnosis concealment (see Tables 16 and 17). Contrary to 
expectations, concealment since diagnosis and in the past month were not associated with 
anxiety, depression, cancer-specific distress, social avoidance, and self-esteem (ps ≥ 14). 
Additional exploratory analyses were conducted to identify potential stigma-
related psychological correlates of diagnosis concealment (see Tables 18 & 19). Those 
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who reported concealing since diagnosis (p = .01) and those who reported concealing in 
the past month (p < .01) reported greater internalized shame related to the diagnosis of 
lung cancer. Perceived social rejection, financial insecurity, perceived social isolation, 
and total perceived stigma were not associated with diagnosis concealment since 
diagnosis or in the past month (ps ≥ .20).  
Additional exploratory analyses for concealment from close family/friends 
Additional exploratory analyses were conducted to identify potential predictors 
and correlates of diagnosis concealment from close family or friends versus more distant 
others or not at all (see Tables 20, 21, 22, and 23). In order to conduct these analyses, the 
sample was dichotomized between those who reported concealing from close family or 
friends versus those who did not report concealing or else reported concealing from other 
family, work supervisors, co-workers, and/or casual friends. Analyses were conducted 
separately for concealment since diagnosis and in the past month. Analyses indicated that 
20 (17%) participants reported concealing from close family or friends since their 
diagnosis and 15 (13%) reported concealing from close family or friends in the past 
month. 
Regarding predictors, neither sex, age, smoking history, nor marital status were 
associated with concealment from close friends/family since diagnosis (ps ≥ .39) or in the 
past month (ps ≥ .18). Poorer social support was associated with concealment from close 
family/friends since diagnosis (p = .03) and in the past month (p = .03). Concealment 
from close family/friends since diagnosis and in the past month were not associated with 
introversion, social anxiety, and use of seeking guidance and support (ps ≥ .07).  
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 Regarding correlates, diagnosis concealment from close family/friends since 
diagnosis and in the past month were not associated with anxiety, depression, cancer-
specific distress, social avoidance, and self-esteem (ps ≥ .08). 
Mediational analyses 
Exploratory mediational analyses were conducted to determine whether the 
relationships between concealment (since diagnosis and in the past month) and affective 
correlates were mediated by social avoidance and self-esteem. Self-esteem did not 
mediate the relationships between diagnosis concealment (since diagnosis or in the past 
month) with anxiety, depression, or cancer-specific distress, ps > .05. Social avoidance 
did not mediate the relationships between diagnosis concealment (since diagnosis or in 
the past month) with anxiety, depression, and cancer-specific distress, ps > .05.  
Additional exploratory analysis 
 An additional exploratory analysis was conducted to examine whether perceived 
stigma was associated with depression. Greater perceived stigma was associated with 
greater depressive symptomatology, r(114) =  .35, p < .01. 
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Table 1 
Demographic Characteristics of the Sample (N = 117)  
 
Variable M SD 
 
Age, years 64.22 (9.66) 
 
Pack years of tobacco usea 42.52 (29.96) 
  
Variable n % 
 
Gender 
  Males 58 (49.6%) 
  Females 59 (50.4%) 
 
Education  
  ≤  High school graduate     35 (29.9%) 
  >  High school graduate 82 (70.1%) 
 
Race 
  White 96 (82.1%) 
  Non-white 21 (17.9%) 
 
Ethnicity 
  Hispanic 5 (4.3%) 
  Non-hispanic       112 (95.7%) 
 
Marital Status 
  Currently married      73 (62.4%) 
  Not married        44 (37.6%) 
 
Total household income 
  < $ 40,000 29 (24.8%) 
  ≥ $40,000 69 (59.0%) 
  Declined to answer 19 (16.2%) 
 
Alcohol use in past month 
 No 69 (59.0%) 
 Yes 48 (41.0%) 
 
Cigarette use 
 Never 26 (22.2%) 
 Previous & current 91 (77.7%) 
 
Note. aAmong only past smokers and current smokers (n = 91).  
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Table 2 
Clinical Characteristics of the Sample (N = 117) 
 
Variable M SD 
 
Body mass index 26.33 (5.19) 
 
Months since original diagnosis 20.56 (27.92) 
 
Months since recurrencea 9.74 (9.53) 
 
Months since resectionb 26.46 (32.75) 
 
Months since radiationc 13.40 (21.70) 
 
Variable n % 
 
Type of lung cancer 
 NSCLC 104 (88.9%) 
 SCLC 13 (11.1%) 
 
NSCLC disease staged 
 I – II 14 (12.0%) 
 III 17 (14.5%) 
 IV 73 (62.4%) 
 
SCLC disease stagee 
 Limited stage SCLC 2 (15.4%) 
 Extensive stage SCLC 11 (84.6%) 
 
ECOG performance status 
 0 23 (19.7%) 
 1 84 (71.8%) 
 2 - 4 10 (8.5%) 
 
Taking antidepressant medication at time of study visit 
  No 92 (78.6%) 
  Yes 25 (21.4%) 
 
Taking sedative/hypnotic medication at time of study visit 
  No 67 (57.3%) 
  Yes 50 (42.7%) 
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Table 2 (Continued) 
Had a recurrence 
  No 90 (76.9%) 
  Yes 27 (23.1%) 
 
Had resection of this cancer 
  No 80 (68.4%) 
  Yes 37 (31.6%) 
 
Had radiation therapy for this cancer  
  Never 67 (57.3%) 
  Finished radiation before consent 42 (35.9%) 
  Receiving radiation 8 (6.8%) 
 
Had chemotherapy for this cancer 
 Never 1 (0.9%) 
 Receiving chemotherapy 116 (99.1%) 
 
Note. ECOG = Eastern Cooperative Oncology Group. NSCLC = non-small cell lung 
cancer. SCLC = small cell lung cancer. aAmong only those with a recurrence (n = 27). 
bAmong only those with a resection (n = 37). cAmong only those with radiation (n = 50). 
dAmong only those with NSCLC (n = 104). eAmong only those with SCLC (n = 13). 
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Table 3 
Frequencies of Concealment Since Diagnosis From Various Groups (n = 36) 
Concealment From Yes No N/A Sum 
Close family 11 (30.6%) 25 (69.4%) -- 36 
Other family 10 (27.8%) 26 (72.2%) -- 36 
Work supervisor 2 (5.6%) 12 (33.3%) 22 (61.1%) 36 
Co-worker 4 (11.1%) 8 (22.2%) 24 (66.7%) 36 
Close friend 13 (36.1%) 23 (63.9%) -- 36 
Casual friend 25 (69.4%) 11 (30.6%) -- 36 
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Table 4 
Frequencies of Concealment in Past Month From Various Groups (n = 30) 
Concealment From Yes No N/A Sum 
Close family 5 (16.7%) 25 (83.3%) -- 30 
Other family 8 (26.7%) 22 (73.3%) -- 30 
Work supervisor 0 (0.0%) 13 (43.3%) 17 (56.7%) 30 
Co-worker 4 (13.3%) 6 (20.0%) 20 (66.7%) 30 
Close friend 12 (40.0%) 18 (60.0%) -- 30 
Casual friend 20 (66.7%) 10 (33.3%) -- 30 
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Table 5 
Frequencies of Reasons for Concealment From Various Groups  
Since Diagnosis (N = 117) 
Concealment From n % 
Close family   
   I didn’t want them to worry about me 4 36.4% 
   Other 3 27.3% 
   I didn’t want to overburden them 2 18.2% 
   Missing 2 18.2% 
Other family   
   I didn’t want them to worry about me 6 60.0% 
   I didn’t want them to take pity on me 3 30.0% 
   I didn’t want to overburden them 1 10.0% 
Work supervisor   
   They might think I’d take too much time off 1 50.0% 
   Other 1 50.0% 
Co-worker   
   Other 2 60.0% 
   I didn’t want to overburden them 1 20.0% 
   I was concerned that they might judge me 1 20.0% 
Close friend   
   I didn’t want them to worry about me 7 53.8% 
   I didn’t want them to take pity on me 4 30.8% 
   I didn’t want to overburden them 1 7.7% 
   Other 1 7.7% 
Casual friend   
   Other 11 44.0% 
   I didn’t want them to take pity on me 8 32.0% 
   I didn’t want them to worry about me 4 16.0% 
   I didn’t want to overburden them 1 4.0% 
   I thought they might avoid me 1 4.0% 
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Table 6 
Frequencies of Reasons for Concealment From Various Groups in the  
Past Month (N = 117) 
Concealment From n % 
Close family   
   I didn’t want to overburden them 2 40.0% 
   I didn’t want them to worry about me 1 20.0% 
   Other 1 20.0% 
   Missing 1 20.0% 
Other family   
   I didn’t want them to worry about me 5 62.5% 
   I didn’t want them to take pity on me 2 25.0% 
   I didn’t want to overburden them 1 12.5% 
Co-worker   
   Other 3 75.0% 
   I was concerned that they might judge me 1 25.0% 
Close friend   
   I didn’t want them to worry about me 7 58.3% 
   I didn’t want them to take pity on me 3 5.0% 
   I didn’t want to overburden them 1 8.3% 
   Other 1 830.0% 
Casual friend   
   Other 10 52.6% 
   I didn’t want them to take pity on me 6 31.6% 
   I didn’t want them to worry about me 2 10.5% 
   I didn’t want to overburden them 1 4.0% 
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Table 7 
Demographics of Participants Who Did Not Conceal Compared to Those Who Did 
Conceal  
Since Diagnosis (N = 117)  
  Did conceal 
Did not 
conceal 
    
  (n = 36) (n = 81)     
Variable M (SD) M (SD) t P 
Age, years 62.7 (10.44) 64.9 (9.25) 1.15 .26 
Pack years of tobacco usea 45.9 (30.22) 39.9 (28.65) -.90 .37 
Variable n (%) n (%) χ2 p 
Gender   0.55 .46 
  Males 16 (13.7%) 42 (35.9%)   
  Females 20 (17.1%) 39 (33.3%)   
Education   0.60 .44 
  ≤  High school graduate 9 (7.7%) 26 (23.1%)   
  >  High school graduate 26 (22.2%) 55 (47.0%)   
Race   0.65 .42 
  White 28 (23.9%) 68 (58.1%)   
  Non-white 8 (6.8%) 13 (11.1%)   
Ethnicity   0.21 .65 
  Hispanic 2 (1.7%) 3 (2.6%)   
  Non-hispanic 34 (29.1%) 78 (66.7%)   
Marital status   1.04 .31 
  Currently married 20 (17.1%) 53 (45.3%)   
  Not married 16 (13.7%) 28 (23.9%)   
Total household income   0.82 .66 
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Table 7 (Continued)     
  < $ 40,000 7 (6.0%) 22 (18.8%)   
  ≥ $40,000 23 (19.7%) 46 (39.3%)   
  Declined to answer 6 (5.1%) 13 (11.1%)   
Alcohol use in past month   2.97 .09 
  No 17 (14.5%) 52 (44.4%)   
  Yes 19 (16.2%) 29 (24.8%)   
Cigarette use   0.23 .63 
  Never 9 (7.7%) 17 (14.5%)   
  Previous & current 27 (23.1%) 64 (54.7%)   
Note. aAmong only past smokers and current smokers (n = 91). 
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Table 8 
Demographics of Participants Who Did Not Conceal Compared to Those Who Did 
Conceal  
in the Past Month (N = 117)  
  Did conceal 
Did not 
conceal 
    
  (n = 30) (n = 87)     
Variable M (SD) M (SD) t P 
Age, years 61.47 (9.93) 65.17 (9.40) 1.84 .07 
Pack years of tobacco usea 46.48 (33.62) 40.22 (27.67) -0.86 .39 
Variable n (%) n (%) χ2 P 
Gender   0.81 .67 
  Males 17 (14.5%) 41 (35.1%)   
  Females 13 (11.1%) 46 (39.3%)   
Education   0.83 .36 
  ≤  High school graduate 7 (6.0%) 28 (23.9%)   
  >  High school graduate 23 (19.7%) 59 (50.4%)   
Race   2.08 .15 
  White 22 (18.8%) 74 (63.2%)   
  Non-white 8 (6.8%) 13 (11.1%)   
Ethnicity   0.57 .45 
  Hispanic 2 (1.7%) 3 (2.6%)   
  Non-hispanic 28 (23.9%) 84 (71.8%)   
Marital status   0.02 .90 
  Currently married 19 (16.2%) 54 (46.2%)   
  Not married 11 (9.4%) 33 (28.2%)   
Total household income   0.99 .61 
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Table 8 (Continued)     
  < $ 40,000 6 (5.1%) 23 (19.7%)   
  ≥ $40,000 20 (17.1%) 49 (41.9%)   
  Declined to answer 4 (3.4%) 15 (12.8%)   
Alcohol use in past month   4.08 .04 
  No 13 (11.1%) 56 (47.9%)   
  Yes 17 (14.5%) 31 (26.5%)   
Cigarette use   1.41 .24 
  Never 9 (7.7%) 17 (14.5%)   
  Previous & current 21 (17.9%) 70 (59.8%)   
Note. aAmong only past smokers and current smokers (n = 91). 
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Table 9 
Clinical Characteristics of Participants Who Did Not Conceal Compared to Those Who 
Did Conceal Since Diagnosis (N = 117) 
  Did conceal 
Did not 
conceal 
    
  (n = 36) (n = 82)     
Variable M (SD) M (SD) t P 
Body mass index 26.2 (4.97) 26.4 (5.31) 0.20 .85 
Months since original diagnosis 23.0 (29.60) 19.5 (27.26) -0.64 .53 
Months since recurrencea 5.6 (5.99) 12.6 (10.61) 1.95 .06 
Months since resectionb 31.2 (34.51) 24.2 (32.35) -0.60 .55 
Months since radiationc 20.2 (34.86) 11.0 (14.60) -1.33 .19 
Variable n (%) n (%) χ2 p 
Type of lung cancer   0.41 .52 
  NSCLC 31 (26.5%) 73 (62.4%)   
  SCLC 5 (4.3%) 8 (6.8%)   
NSCLC disease staged   0.05 > .99 
  I – II 4 (3.8%) 10 (9.6%)   
  III 5 (4.8%) 12 (11.5%)   
  IV 21 (21.2%) 51 (49.0%)   
SCLC disease stagee   0.13 .72 
  Limited stage SCLC 1 (7.7%) 1 (7.7%)   
  Extensive stage SCLC 4 (30.8%) 7 (53.8%)   
ECOG performance status   2.67 .45 
  0 10 (8.5%) 13 (11.1%)   
  1 23 (19.7%) 61 (52.1%)   
  2 – 4 3 (2.6%) 7 (6.0%)   
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Table 9 (Continued)   
Taking antidepressant medication  
0.11 .74 
at time of study visit 
  No 29 (24.8%) 63 (53.8%)   
  Yes 7 (6.0%) 18 (15.4%)   
Taking sedative/hypnotic medication  
0.02 .87 
at time of study visit 
  No 21 (17.9%) 46 (39.3%)   
  Yes 15 (12.8%) 35 (29.9%)   
Had a recurrence   1.64 .20 
  No 25 (21.4%) 65 (55.6%)   
  Yes 11 (9.4%) 16 (13.7%)   
Had resection of this cancer   0.07 .79 
  No 24 (20.5%) 56 (47.9%)   
  Yes 12 (10.3%) 25 (21.4%)   
Had radiation therapy for this cancer  1.52 .47 
  Never 23 (19.7%) 44 (37.6%)   
  Finished radiation before 
consent 
10 (8.5%) 32 (27.4%)   
  Receiving radiation 3 (2.6%) 5 (4.3%)   
Had chemotherapy for this cancer  2.27 .13 
  Never 1 (0.9%) 0 (0.0%)   
  Receiving chemotherapy 35 (29.9%) 81 (69.2%)   
 
Note. ECOG = Eastern Cooperative Oncology Group. NSCLC = non-small cell lung 
cancer. SCLC = small cell lung cancer. aAmong only those with a recurrence (n = 27). 
bAmong only those with a resection (n = 37). cAmong only those with radiation (n = 50). 
dAmong only those with NSCLC (n = 104). eAmong only those with SCLC (n = 13).  
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Table 10 
Clinical Characteristics of Participants Who Did Not Conceal Compared to Those Who 
Did Conceal in the Past Month (N = 117) 
  Did conceal 
Did not 
conceal 
    
  (n = 30) (n = 82)     
Variable M (SD) M (SD) t p 
Body mass index 25.79 (4.97) 26.52 (5.27) 0.66 .51 
Months since original 
diagnosis 
22.03 (30.94) 20.05 (26.97) -0.34 .74 
Months since recurrencea 4.22 (2.73) 12.50 (10.55) 3.13 < .01 
Months since resectionb 31.17 (34.51) 24.20 (32.35) -0.60 .55 
Months since radiationc 19.83 (36.35) 11.37 (15.00) -1.18 .24 
Variable n (%) n (%) χ2 p 
Type of lung cancer   3.23 .07 
  NSCLC 24 (20.5%) 80 (68.4%)   
  SCLC 6 (5.1%) 7 (6.0%)   
NSCLC disease staged                                                                                                                                                                                                                                                                                                           0.56 .91                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  I - II 4 (3.8%) 10 (9.6%)   
  III 3 (2.9%) 14 (13.5%)   
  IV 17 (16.3%) 56 (53.8%)   
SCLC disease stagee   0.01 .91 
  Limited stage SCLC 1 (7.7%) 1 (7.7%)   
  Extensive stage SCLC 5 (38.5%) 6 (46.2%)   
ECOG performance status   3.00 .39 
  0 9 (7.7%) 14 (12.0%)   
  1 19 (16.2%) 65 (55.6%)   
  2 - 4 2 (1.7%) 8 (6.9%)   
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Table 10 (Continued)     
Taking antidepressant medication at time of study visit 0.09 .76   
  No 23 (19.7%) 69 (59.0%)   
  Yes 7 (6.0%) 18 (15.4%)   
Taking sedative/hypnotic medication at time of study visit 1.46 .23 
  No 20 (17.1%) 47 (40.2%)   
  Yes 10 (8.5%) 40 (34.2%)   
Had a recurrence   1.09 .30 
  No 21 (17.9%) 69 (59.0%)   
  Yes 9 (7.7%) 18 (15.4%)   
Had resection of this cancer   1.31 .25 
  No 18 (15.4%) 62 (53.0%)   
  Yes 12 (10.3%) 25 (21.4%)   
Had radiation therapy for this cancer  0.13 .94 
  Never 18 (15.4%) 49 (41.9%)   
  Finished radiation before 
consent 
10 (8.5%) 32 (27.4%)   
  Receiving radiation 2 (1.7%) 6 (5.1%)   
Had chemotherapy for this cancer  0.35 .56 
  Never 0 (0.0%) 1 (0.9%)   
  Receiving chemotherapy 30 (25.6%) 86 (73.5%)     
Note. ECOG = Eastern Cooperative Oncology Group. NSCLC = non-small cell lung 
cancer. SCLC = small cell lung cancer. aAmong only those with a recurrence (n = 27). 
bAmong only those with a resection (n = 37). cAmong only those with radiation (n = 50). 
dAmong only those with NSCLC (n = 104). eAmong only those with SCLC (n = 13). 
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Table 11 
Psychological Predictors of Concealment in Participants Who Did Not Conceal 
Compared to Those Who Did Conceal Since Diagnosis (N = 117). 
 Did conceal Did not conceal 
 (n = 36) (n = 80)  
Variable M (SD) M (SD) Wald χ2 p 
Introversion 27.1 (7.02) 28.6 (6.34) 1.32 .25 
Social Anxiety 12.5 (10.33) 13.7 (12.68) 0.26 .61 
Social Support 22.2 (4.06) 22.5 (3.72) 0.01 .92 
Seeking Guidance & Support 52.4 (8.09) 53.9 (8.52) 0.74 .39 
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Table 12 
Psychological Predictors of Concealment in Participants Who Did Not  
Conceal Compared to Those Who Did Conceal in the Past Month (N = 117) 
 Did conceal Did not conceal 
 (n = 30) (n = 87)  
Variable M (SD) M (SD) Wald χ2 p 
Introversion 26.6 (6.39) 28.6 (6.58) 2.12 .15 
Social Anxiety 12.2 (10.72) 13.7 (12.42) 0.39 .54 
Social Support 22.1 (3.93) 22.5 (3.79) 0.03 .85 
Seeking Guidance & Support 53.9 (8.16) 53.3 (8.50) 0.09 .77 
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Table 13 
Psychological Predictors of Concealment in Participants Who Did Not  
Conceal Compared to Those Who Did Conceal Since Diagnosis (N = 117)  
 
 Did conceal Did not conceal 
 (n = 36) (n = 80)  
 
Variable M (SD) M (SD) Wald χ2 p 
Private Self-Consciousness 12.69 (4.33) 11.36 (4.23) 2.30 .13 
Public Self-Consciousness 12.40 (5.83) 10.43 (6.60) 2.15 .14  
CRI Logical Analysis 46.14 (7.46) 45.06 (15.75) 0.13 .72  
CRI Positive Reappraisal 55.00 (6.39) 53.22 (8.34) 1.17 .28  
CRI Problem-Solving 52.88 (6.46) 52.15 (8.75) 0.17 .68  
CRI Cognitive Avoidance 49.66 (8.16) 50.96 (8.76) 0.51 .48  
CRI Acceptance or Resignation 51.08 (10.20) 49.19 (8.35) 0.99 .32  
CRI Seeking Alternative Rewards 51.76 (9.89) 53.52 (9.19) 0.78 .38  
CRI Emotional Discharge 54.02 (9.08) 51.33 (8.13) 2.27 .13  
Note. CRI = Coping Responses Inventory. SIS = Social Impact Scale.  
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Table 14 
Psychological Predictors of Concealment in Participants Who Did Not  
Conceal Compared to Those Who Did Conceal in the Past Month (N = 117)  
 
 Did conceal Did not conceal 
 (n = 30) (n = 87)  
 
Variable M (SD) M (SD) Wald χ2 p 
Private Self-Consciousness 12.76 (4.01) 11.43 (4.34) 2.07 .15 
Public Self-Consciousness 12.52 (5.70) 10.52 (6.60) 1.96 .16 
CRI Logical Analysis 46.26 (8.14) 45.09 (15.27) 0.14 .71  
CRI Positive Reappraisal 56.94 (4.64) 52.70 (8.39) 5.63 .02 
CRI Problem-Solving 52.66 (5.88) 52.27 (8.72) 0.04 .84 
CRI Cognitive Avoidance 49.97 (8.63) 50.78 (8.61) 0.18 .67 
CRI Acceptance or Resignation 50.03 (10.34) 49.64 (8.61) 0.04 .85 
CRI Seeking Alternative Rewards 52.35 (9.92) 53.22 (9.26) 0.17 .68 
CRI Emotional Discharge 53.18 (8.24) 51.78 (8.55) 0.54 .46 
Note. CRI = Coping Responses Inventory. SIS = Social Impact Scale. 
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Table 15 
Psychological Predictors of Discomfort With Concealing or Disclosing One’s Diagnosis 
in the Past Month (N = 117) 
Discomfort 
level 
 Introversion 
Social 
Anxiety 
Social 
Support 
Seeking 
Guidance & 
Support 
 n (%) M (SD) M (SD) M (SD) M (SD) 
No 
discomfort 
51 (43.6%) 28.02 (6.24) 9.82 (10.83) 22.78 (3.61) 53.28 (8.86) 
A little 
discomfort 
24 (20.5%) 28.29 (6.71) 15.21 (10.40) 22.17 (3.20) 53.96 (7.72) 
Mild 
discomfort 
19 (16.2%) 28.00 (7.36) 18.68 (15.2) 21.72 (3.80) 54.41 (8.01) 
Moderate 
discomfort 
16 (13.7%) 26.06 (5.70) 16.07 (12.50) 20.81 (6.63) 50.40 (8.68) 
Extreme 
discomfort 
7 (6.0%) 33.43 (7.09) 12.07 (8.06) 23.43 (3.31) 57.79 (6.54) 
  
rho = .009 rho = .265 rho = -.066 rho = .011 
p = .92 p < .01 p = .48 p = .91 
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Table 16 
Psychological Correlates of Concealment in Participants Who Did Conceal Compared to 
Those Who Did Not Conceal Since Diagnosis (N = 117)  
 
 Did conceal Did not conceal 
 (n = 36) (n = 80)  
 
Variable M (SD) M (SD) r p 
Anxiety 13.06 (3.14) 12.44 (3.50) .085 .37 
Depression 14.03 (2.98) 14.11 (2.80) -.014 .88 
Cancer-Specific Distress 0.78 (0.73) 0.90 (0.73) -.074 .43 
Social Avoidance 16.49 (10.26) 18.25 (13.31) -.066 .48 
Self-Esteem 23.91 (4.95) 22.32 (5.37) .160 .14 
 
 
  
47 
 
Table 17 
Psychological Correlates of Concealment in Participants Who Did Not Conceal 
Compared to  
Those Who Did Conceal in the Past Month (N = 117)  
 
 Did conceal Did not conceal 
 (n = 30) (n = 87)  
 
Variable M (SD) M (SD) r p 
Anxiety 13.40 (2.93) 12.36 (3.52) .135 .15  
Depression 14.10 (3.10) 14.08 (2.77) .003 .98 
Cancer-Specific Distress 0.81 (0.76) 0.89 (0.72) -.045 .64 
Social Avoidance 17.17 (10.55) 17.89 (13.06) -.026 .79 
Self-Esteem 23.10 (5.07) 22.70 (5.37) .033 .72 
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Table 18 
Psychological Correlates of Concealment in Participants Who Did Not Conceal  
Compared to Those Who Did Conceal Since Diagnosis (N = 117)  
 
 Did conceal Did not conceal 
 (n = 36) (n = 80)  
 
Variable M (SD) M (SD) r p 
SIS Social Rejection 12.72 (3.15) 13.65 (4.31) -.108 .25 
SIS Financial Insecurity 4.25 (1.99) 4.84 (2.37) -.120 .20 
SIS Internalized Shame 9.61 (2.50) 8.36 (2.50) .227 .01 
SIS Social Isolation 13.42 (3.59) 13.66 (4.51) -.027 .77 
SIS Total Perceived Stigma 40.00 (8.48) 40.51 (11.25) -.023 .81 
Note. SIS = Social Impact Scale.  
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Table 19 
Psychological Correlates of Concealment in Participants Who Did Not Conceal  
Compared to Those Who Did Conceal in the Past Month (N = 117)  
 
 Did conceal Did not conceal 
 (n = 30) (n = 87)  
 
Variable M (SD) M (SD) r p 
SIS Social Rejection 13.60 (3.32) 13.28 (4.22) .035 .71 
SIS Financial Insecurity 4.50 (2.13) 4.71 (2.32) -.041 .67 
SIS Internalized Shame 9.93 (2.59) 8.34 (2.42) .275 < .01 
SIS Social Isolation 13.93 (3.37) 13.47 (4.51) .049 .60 
SIS Total Perceived Stigma 41.97 (8.42) 39.79 (11.03) .092 .33 
Note. SIS = Social Impact Scale.  
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Table 20 
Psychological Predictors of Concealment in Participants Who Did Not Conceal From  
Close Family/Friends Compared to Those Who Did Conceal Since Diagnosis (N = 117)  
 
 Did conceal from Did not conceal 
 close family/friends 
 (n = 20) (n = 97)  
Variable M (SD) M (SD) Wald χ2 p  
Introversion 26.85 (8.24) 28.40 (6.18) 0.92 .34 
Social Anxiety 9.58 (8.43) 14.11 (12.48) 2.32 .13 
Social Support 20.58 (4.74) 22.59 (3.89) 4.59 .03 
Seeking Guidance & Support 53.01 (8.23) 53.55 (8.46) 0.07 .80 
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Table 21 
Psychological Correlates of Concealment in Participants Who Did Not Conceal From  
Close Family/Friends Compared to Those Who Did in the Past Month (N = 117)  
 
 Did conceal from Did not conceal 
 close family/friends 
 (n = 15) (n = 102)  
Variable M (SD) M (SD) Wald χ2 p 
Introversion 25.20 (6.81) 28.56 (6.45) 3.34 .07 
Social Anxiety 10.13 (9.29) 13.81 (12.29) 1.22 .97 
Social Support 20.14 (4.37) 22.55 (3.98) 4.82 .03 
Seeking Guidance & Support 52.48 (8.20) 53.60 (8.45) 0.22 .64 
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Table 22 
Psychological Correlates of Concealment in Participants Who Did Not Conceal From  
Close Family/Friends Compared to Those Who Did Conceal Since Diagnosis (N = 117)  
 
 Did conceal from Did not conceal 
 close family/friends 
 (n = 20) (n = 97)  
Variable M (SD) M (SD) r p 
Anxiety 13.45 (3.35) 12.46 (3.40) .105 .26 
Depression 13.90 (3.18) 14.13 (2.78) -.023 .81 
Cancer-Specific Distress 0.74 (0.75) 0.89 (0.73) -.082 .38 
Social Avoidance 15.23 (9.77) 18.22 (12.89) -.085 .37 
Self-Esteem 23.58 (5.71) 22.65 (5.20) .143 .16 
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Table 23 
Psychological Correlates of Concealment in Participants Who Did Not Conceal From  
Close Family/Friends Compared to Those Who Did Conceal In the Past Month (N = 
117)  
 
 Did conceal from Did not conceal 
 close family/friends 
 (n = 15) (n = 102)  
 
Variable M (SD) M (SD) r p 
Anxiety 14.07 (2.46) 12.42 (3.47) .162 .08 
Depression 13.80 (3.38) 14.13 (2.77) -.017 .86 
Cancer-Specific Distress 0.81 (0.82) 0.87 (0.72) -.041 .66 
Social Avoidance 17.33 (10.15) 17.76 (12.76) -.021 .82 
Self-Esteem 22.71 (5.90) 22.81 (5.21) .056 .59 
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Figure 3. Participant Flow Chart 
Assessed for eligibility 
(n= 1,447) 
Potentially eligible, but not 
approached (n = 184) 
Consented 
(n = 153) 
Approached for consent 
(n = 196) 
Refused to participate 
(n = 39) 
Ineligible before consent 
(n = 4) 
Withdrew from study 
(n = 4) 
Failed to complete measures 
(n = 29) 
Ineligible after consent 
(n = 3) 
Completed study measures 
(n = 117) 
Ineligible for participation 
(n = 1,067) 
55 
 
 
 
 
 
 
Discussion 
Summary of Results  
A primary aim of this study was to determine the prevalence of diagnosis 
concealment among individuals receiving treatment for lung cancer. This study also 
sought to evaluate potential predictors of concealment as well as potential correlates of 
concealment. 
 Results indicated that 31% of participants reported concealing their lung cancer 
diagnosis from others since their diagnosis; 26% reported concealing their diagnosis in 
the month preceding their participation in the study. Most participants who reported 
concealing since diagnosis as well as in the past month indicated they concealed from 
casual friends. Additional analyses indicated that one commonly-endorsed reason for 
concealment from family and friends was to avoid having family and friends worry about 
the patient. No published quantitative studies were found which examine rates of 
concealment of one’s cancer diagnosis or any other potentially-stigmatizing condition. 
Thus, this is the first study to examine rates of diagnosis concealment among individuals 
with cancer, and as such it provides new information on rates of concealment and reasons 
for concealment among this population.  
The hypotheses regarding predictors of concealment were not supported. Contrary 
to expectations, gender, introversion, trait social anxiety, and use of seeking guidance and 
support as a coping strategy were not associated with diagnosis concealment since 
diagnosis or in the past month. Exploratory analyses indicated that those who reported 
56 
 
drinking alcohol in the past month were more likely to conceal their diagnosis in the past 
month; there was also a trend for those who reported drinking alcohol in the past month 
to be more likely to conceal since diagnosis. Participants who had a recurrence of their 
lung cancer more recently were more likely to conceal their diagnosis in the past month; 
there was a trend for a similar relationship suggesting that those who recurred more 
recently were also more likely to conceal their diagnosis since the original diagnosis. In 
addition, those who reported greater use of positive reappraisal as a coping tool were 
more likely to conceal their diagnosis in the past month. Trait social anxiety was related 
to discomfort regarding concealment or disclosure of one’s diagnosis in the past month. 
Lastly, those who concealed their diagnosis from close family or friends since diagnosis 
and in the past month reported poorer social support.   
The Pachankis (2007) model of the effects of concealing a concealable stigma is 
silent on theoretical predictors of the decision to conceal one’s stigma. Although 
hypotheses for predictors of concealment based on findings in other populations were not 
supported, use of alcohol, recency of a recurrence of lung cancer, use of positive 
reappraisal as a coping strategy, and social support were identified as predictors of 
concealment among individuals with lung cancer.  The observed relationship between 
poorer social support and concealment is in line with previous literature showing poorer 
social support among those who concealed a diagnosis of HIV (Petrak et al., 2001). This 
finding suggests the Pachankis (2007) model may benefit from revision to include social 
support. Relationships between concealment with use of alcohol, recency of recurrence of 
lung cancer, and use of positive reappraisal as a coping strategy have not been found in 
the existing literature. Individuals with more recent recurrences have experienced a major 
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setback in their lung cancer treatment, which may reinforce the reported reasons to 
conceal their diagnosis (e.g., to avoid others’ concern for them). Those who used of 
alcohol, which may be an indicator of a maladaptive coping strategy, may be more likely 
to resort to concealment when considering the potential negative psychosocial outcomes 
of disclosing their illness. Similarly, those who endorsed greater use of positive 
reappraisal as a coping strategy, an adaptive coping strategy, may have been more likely 
to focus on the positive aspects of concealment (e.g., greater privacy). These findings 
should be considered for inclusion as predictors in the model, pending replications. 
Hypotheses regarding correlates of concealment were also not supported. 
Anxiety, depression, cancer-specific distress, social avoidance, and self-esteem were not 
associated with diagnosis concealment since diagnosis or in the past month. Exploratory 
analyses indicated that those who concealed their diagnosis since diagnosis and in the 
past month reported greater internalized shame regarding their diagnosis. The 
identification of internalized shame as a correlate of diagnosis concealment is important 
in that it supports the Pachankis (2007) model’s association between concealment and 
shame, an affective implication of concealment. 
Theoretical implications  
When contemplating the lack of support for hypotheses of correlates of 
concealment, it is important to consider that Pachankis’ (2007) model focuses on 
individual situations that might elicit behavioral, affective, and cognitive consequences. It 
indicates that among individuals who conceal a stigma, situations in which one’s stigma 
is salient, there is a high threat of discovery, and there would be negative consequences 
for discovery would result in negative affective, behavioral, and self-evaluative 
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outcomes. Rather than examining the social interactions of participants who concealed 
their stigma, this study examined broader implications of concealing one’s stigma based 
on the model’s theorized. Thus, it is possible that the negative consequences of 
concealing one’s stigma and undergoing situations with high stigma salience, high threat 
of discovery, and dire consequences of discovery were not detectable by this study’s 
measures or were not significant enough to impact participants’ overall well-being. That 
is, concealing a concealable stigma such as lung cancer may result in negative 
consequences during and after the above-mentioned situations. However, these negative 
consequences may be short-lived and go unnoticed in a retrospective study such as the 
current study. 
Another possible explanation for the lack of support for the study’s hypotheses 
involves the reasons for concealment. Many participants reported concealing for what 
appeared to be altruistic reasons (e.g., “I didn’t want them to worry about me”). Thus, it 
is possible that the situations within which the study’s participants concealed their stigma 
did not meet the description provided by Pachankis of situations that would elicit 
negative consequences. Specifically, these situations may not have possessed sufficiently 
high threat of negative consequences for disclosure of one’s stigma. That is, the potential 
negative consequence of disclosure (i.e., their loved one’s excessive worry about them), 
may not have been sufficiently negative to elicit the negative affective, behavioral, and 
self-evaluative consequences proposed by Pachankis (2007).  
Clinical implications 
 With regard to clinical implications, the findings suggest that oncologists and 
mental healthcare professionals treating individuals with cancer consider discussing 
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concealment or disclosure of their diagnosis with their patients. The data suggest that 
those who conceal their illness may be more likely to experience internalized shame 
regarding their illness. Although concealment was not associated with affective outcomes 
in this study, internalized shame has been associated with greater depressive 
symptomatology among individuals with lung cancer in previous research (Gonzalez & 
Jacobsen, 2011) and perceived stigma was associated with depressive symptoms in the 
current study. Addressing this potential impact of concealment of one’s diagnosis could 
prove beneficial in avoiding depressive symptoms and their negative sequelae if, as 
hypothesized by Pachankis (2007), concealment results in greater shame. It is also 
conceivable that one’s internalized shame may cause them to conceal their diagnosis, 
which may result in other negative behavioral, affective, and cognitive outcomes. 
Limitations and future directions 
 The cross-sectional nature of this study’s data collection limits the conclusions 
that can be drawn from its findings. Although the data can be interpreted as suggesting 
that use of positive reappraisal as a coping strategy, greater trait social anxiety, and 
poorer social support increase the likelihood that a person with lung cancer will conceal 
their diagnosis and that concealment contributes to greater internalized shame, the 
possibility of reverse relationships between these measures cannot be ruled out. One way 
to better establish causality would be to conduct in vivo studies that examine the impact 
of concealing vs. disclosing a lung cancer diagnosis to confederate strangers. These 
studies could more closely examine the impacts of concealing in various situations and 
could elucidate temporal relationships between predictors and consequences of 
concealment.  
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The sample’s homogeneity with regard to race and ethnicity limits the ability to 
generalize to the broader population of individuals with lung cancer. Future studies 
should aim to recruit more diverse samples of individuals with lung cancer, especially 
with respect to racial, ethnic, and socioeconomic diversity. Similarly, participants in this 
study were receiving chemotherapy and/or radiotherapy for their lung cancer; thus, the 
study’s findings may not generalize to individuals receiving other types of treatments or 
receiving no treatment at all.  
Although the prescription of antidepressant and sedative/hypnotic medications 
were not related to concealment in this study, participants’ use of psychotherapy and 
related services was not assessed. Thus, the potential buffering effect of these services 
could not be ascertained. Future studies should more closely examine the impacts that 
psychotherapy and related services may have on the negative outcomes hypothesized to 
result from concealment. 
Another limitation of this study is the treatment of concealment as a dichotomous 
variable. This approach may have artificially increased the error in the measurement of 
concealment, thereby reducing the study’s power to identify significant effects. Future 
studies should examine the frequency of concealment or study concealment as a 
continuous variable by measuring the varying degrees of concealment from others. In 
addition, the validity of the concealment measure used in this study should be better 
established. Future studies should examine whether patient reports of diagnosis 
concealment or disclosure could be corroborated with reports from significant others in a 
manner that would not violate patient privacy. 
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Beyond addressing these limitations, future research should examine the 
possibility that concealment or disclosure results in negative consequences for only 
certain subgroups of individuals. For example, it may be that only those with greater 
social anxiety experience poorer self-esteem as a result of concealment. It may also be 
that only those with poorer social support experience greater social avoidance and 
depression as a result of concealment.   
Conclusions 
 This study, the first to examine predictors of diagnosis concealment and to test a 
model of the impacts of concealment on individuals with cancer, demonstrated that 31% 
of participants concealed their diagnosis from others since their diagnosis and 26% 
concealed their diagnosis in the month preceding their participation in the study. 
Exploratory analyses identified predictors of concealment, including use of alcohol, 
recency of a recurrence of lung cancer, use of positive reappraisal as a coping strategy, 
and social support. Internalized shame was also identified as a correlate of concealment 
in this study. These findings support parts of the Pachankis (2007) model on the effects of 
concealment and suggest that the model should be modified to include predictors of 
concealment. Future research should aim to replicate these findings and examine 
predictors and consequences of concealment in the context of certain social situations in 
order to test temporal relationships.   
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